PROCEPT BioRobotics Corporation Common Stock Profile
About
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif.
Info & Links
CEO
Reza Zadno
Headquarters
150 Baytech Drive San Jose, CA 95134, UNITED STATES
PROCEPT BioRobotics Corporation Common Stock Statistics
Valuation Measures
Market Capitalization2
1.78B
Enterprise Value
1.54B
Enterprise Value/EBITDA(ttm)
-17.84
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
6.29
Price to Book(mrq)
4.96
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
64.50%
Operating Margin(ttm)
-28.20%
Profit Margin(ttm)
-28.46%
Return on Equity(ttm)
-21.72%
Return on Invested Capital(ttm)
-19.20%
Return on Assets(ttm)
-16.28%
Income Statement
Revenue(ttm)
299.91M
Revenue Per Share(ttm)
5.37
Gross Profit(ttm)
193.59M
EBITDA(ttm)3
-86.40M
Net Income Available to Common(ttm)
-84.58M
Diluted EPS(ttm)
-1.53
Share Statistics
Beta (5Y Monthly)
0.99
52-Week Change
-61.13%
S&P 500 52-Week Change
16.48%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
55.88M
Dividend Yield
0.00%
Float4
52.19M
% Held by Insiders
6.60%
% Held by Institutions
89.46%
Balance Sheet
Total Cash(mrq)
294.28M
Total Cash Per Share(mrq)
5.27
Total Debt(mrq)
51.57M
Total Debt/Equity(mrq)
13.56%
Current Ratio(mrq)
8.44%
Quick Ratio(mrq)
7.20%
Book Value Per Share(mrq)
6.81
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.69
Free Cash Flow(ytd)
-46.16M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.